Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
Background: Anemia is a common complication in CKD patients. Despite the use of iron and erythropoietin-stimulating agents, the control rate of anemia in CKD is not satisfying. Novel drugs are needed for anemia correction. Summary: HIF-PHI, hypoxia-inducible factor-proline hydroxylase inhibitor, a n...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Karger Publishers,
2020-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|